113P Real-world data from patients with osteosarcoma treated in 4 medical centers in Greece: Ninety percent or greater tumor necrosis is associated with disease-free survival
Myrto Moutafi(University General Hospital Attikon), Amanda Psyrri(National and Kapodistrian University of Athens), Anna Boulouta(National and Kapodistrian University of Athens), Anastasios Pantazopoulos(University General Hospital Attikon), S. Kokkali-Zervos(Hippocration General Hospital), Alexandros Ardavanis(St Savas Hospital), Μaria Anastasiou(National and Kapodistrian University of Athens), Anastasios Kyriazoglou(Alexandra Hospital), Evgenia Magkou(St Savas Hospital), Maria Kirkasiadou(National and Kapodistrian University of Athens), Evridiki Georgaki(Hippocration General Hospital), Ioannis Kotsantis(National and Kapodistrian University of Athens), P. Antonopoulou(National and Kapodistrian University of Athens), I. Boukovinas, Panagiota Economopoulou(National and Kapodistrian University of Athens), Gerasimos Ardavanis(St Savas Hospital), Niki Gavrielatou(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|641